Influence of oral contraceptive use on lipid levels and cardiorespiratory responses among healthy sedentary women

Revista Brasileira de Fisioterapia

Volumn 12, Issue 3, 2008, Pages 188-194

  Santos, M C S ^a   Rebelo, A C S ^a   Zuttin, R S ^a   Cesar M C ^a   Catai, A M ^b   da Silva, Ester ^a  

^a METHODIST UNIVERSITY OF PIRACICABA   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Aerobic capacity; Contraceptive therapy; Heart rate

Indexed keywords

EID: 54949139621     PISSN: 14133555     EISSN: 18099246     Source Type: Journal    
DOI: 10.1590/s1413-35552008000300006     Document Type: Article

References (29)

1. Genazzani AR, Gadducci A, Gambacciani M; International Menopause Society Expert Workshop. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. Maturitas. 2001;40(2):117-30.
2. Sherif K. Benefits and risks of oral contraceptives. Am J Obstet Gynecol. 1999;180(6 Pt 2):S343-8.
3. Foulon T, Payen N, Laporte F, Bijaoui S, Dupont G, Roland F, et al. Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serium lipds and lipoproteins with particular regard to LDL size. Contraception. 2001;64(1):11-6.
4. Notelovitz M, Zauner C, McKenzie L, Suggs Y, Fields C, Kitchens C. The effect of low-dose oral contraceptives on cardiorespiratory function, coagulation, and lipids in exercising young women: a preliminary report. Am J Obstet Gynecol. 1987;156(3):591-8.
5. Bonen A, Haynes FW, Graham TE. Substrate and hormonal responses to exercise in women using oral contraceptives. J Appl Physiol. 1991;70(5):1917-27.
6. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, et al. Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation. 1987;75(6):1102-9.
7. Schueller PO, Feuring M, Sharkova Y, Grimm W, Christ M. Effects of synthetic progestagens on autonomictone, neurohormones and C-reactive protein levels in young healthy females in reproductive age. Int J Cardiol. 2006;111(1):42-8.
8. Davy KP, DeSouza CA, Jones PP, Seals DR. Elevated heart rate variability in physically active young and older adult women. Clin Sci. 1998;94:579-84.
9. Perini R, Fisher N, Veicsteinas A, Pendergast DR. Aerobic training and cardiovascular responses at rest and during exercise in older men and women. Med Sci Sports Exerc. 2002;34(4):700-8.
10. Wiegratz I, Jung-Hoffmann C, Gross W, Kuhl H. Effect of two oral contraceptives containing ethinyl estradiol and gestodene or norgestimate on different lipid and lipoprotein parameters. Contraception. 1998;58(2):83-91.
11. Gaspard U, Endrikat JP, Desager C, Buicu C, Gerlinger R, Helthecker R. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles Contraception. 2004;69(4):271-8.
12. Bergink EW, Kloosterboer HJ, Lund L, Nummi S. Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combination on serum lipids, apolipoproteins A-I and B and glycosylated proteins. Contraception. 1984;30(1):61-72.
13. Silva E, Catai AM, Trevelin LC, Guimarães JO, Silva Jr LP, Silva LMP, et al. Design of a computerized system to evaluate the cardiac function during dynamic exercise. In: Annals of the World Congress on Medical Physics and Biomedical Engineering. 1994;1:419.
14. Casazza GA, Suh SH, Miller BF, Navazio FM, Brooks GA. Effects of oral contraceptives on peak exercise capacity. J Appl Physiol. 2002:93(5):1698-702.
15. Higa MN, Silva E, Neves VF, Catai AM, Gallo L Jr, Silva de Sá MF. Comparison of anaerobic threshold determined by visual and mathematical methods in healthy women. Braz J Med Biol Res. 2007;40(4):501-8.
16. Antila K. Quantitative characterization of heart rate during exercise. Scand J Clin Lab Invest Suppl. 1979;(153):3-68.
17. Stadel BV. Oral contraceptives and cardiovascular disease (first of two parts). N Engl J Med. 1981;305(11):612-8.
18. Schwingl PJ, Ory HW, Visness CM. Estimates of risk of cardiovascular death attributable to low-dose oral contraceptives in the United States. Am J Obstet Gynecol. 1999;180(1 Pt 1):241-9.
19. O'Brien PA. The third generation oral contraceptive controversy. The evidence shows they are less safe than second generation pills. BMJ. 1999;319(7213):795-6.
20. Schwingl PJ, Shelton J. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives. Contraception. 1997;55(3):125-9.
21. Pinotti JA, Bagnoli VR, Fonseca AM, Halbe HW. Fisiologia menstrual. São Paulo: Atheneu; 1994.
22. Teichmann A. Metabolic profile of six oral contraceptives containing norgestimate, gestodene and desogestrel. Int J Fertil Menopausal Stud. 1995; 40 Suppl 2:98-104.
23. Koh KK, Shin MS, Sakuma I, Ann JY, Jin DK, Kim HS, et al. Effects of conventional or lower doses of hormone replacement therapy in postmenopausal women. Aterioscler Thromb Vasc Biol. 2004:24:1516-21.
24. Martins IS, Gomes AD, Pasini U. Serum lipids levels and some risk factors of cardiovascular diseases in a population of the municipality of Sao Paulo, SP (Brazil). Rev Saude Publica. 1989;23(1):26-38.
25. Godsland IF, Crook D, Devenport M, Wynn V. Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception, 1995;52:143-9.
26. Bryner RW, Toffle RC, Ullrich IH, Yeater RA. Effect of low dose oral contraceptives on exercise performance. Br J Sports Med. 1996;30(1):36-40.
27. Giacomoni M, Falgairette G. Decreased submaximal oxygen uptake during short duration oral contraceptive use: a randomized cross-over trial in premenopausal women. Ergonomics. 2000;43(10):1559-70.
28. Neves VF, Silva de Sá MF, Gallo L Jr, Catai AM, Martins LE, Crescnêcio JC, et al. Autonomic modulation of heart rate of young and postmenopausal women undergoing estrogen therapy. Braz J Med Biol Res. 2007;40(4):491-9.
29. Redman LM, Scroop GC, Westlander G, Norman RJ. Effect of a synthetic progestin on the exercise status of sedentary young women. J Clin Endocrinol Metab. 2005;90(7):3830-7.